EU Panel Recommends Luxturna for Inherited Retinal Dystrophy EU Panel Recommends Luxturna for Inherited Retinal Dystrophy
The EMA's CHMP has recommended marketing authorization for voretigene neparvovec for inherited retinal dystrophy caused by RPE65 gene mutations in adults and children.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 21, 2018 Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news

68 people left BLIND after botched cataract cure was injected into their eyeballs
The patients in Dallas had all been promised clear eyesight from the medication, designed to be a permanent alternative for eye drops. But now, most of them are blind in at least one eye. (Source: the Mail online | Health)
Source: the Mail online | Health - September 21, 2018 Category: Consumer Health News Source Type: news

Nationwide Children's gene therapy spinoff acquired for $100M
Yet another gene therapy spinoff from Nationwide Children's Hospital has been acquired for $100 million. Celenex is developing a treatment for Batten Disease, a rare, fatal neurological condition that causes blindness and progressive loss of speech and movement. Children who inherit it typically don't live past age 12. The startup was acquired by Amicus Therapeutics Inc., a Cranbury, New Jersey-base d biotechnology company that focuses on rare metabolic disorders. Columbus-based Rev1 Ventures,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2018 Category: Biotechnology Authors: Carrie Ghose Source Type: news

Nationwide Children's gene therapy spinoff acquired for $100M
Yet another gene therapy spinoff from Nationwide Children's Hospital has been acquired for $100 million. Celenex is developing a treatment for Batten Disease, a rare, fatal neurological condition that causes blindness and progressive loss of speech and movement. Children who inherit it typically don't live past age 12. The startup was acquired by Amicus Therapeutics Inc., a Cranbury, New Jersey-base d biotechnology company that focuses on rare metabolic disorders. Columbus-based Rev1 Ventures,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 21, 2018 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news

Contact Lenses May Harbor Serious, Blinding Infection
Cases of an eye infection called Acanthamoeba keratitis have tripled in southeast England since 2011, a new study found. For one in every four of people infected, the disease results in a loss of most of their vision or blindness, the research team said. It’s typically caused by poor contact lens hygiene. (Source: WebMD Health)
Source: WebMD Health - September 21, 2018 Category: Consumer Health News Source Type: news

Apraclonidin (IOPIDINE) Ophthalmic Solution (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 21, 2018 Category: Drugs & Pharmacology Source Type: news

UK doctors win battle with drug giants over cheaper eye medicine
Drug giants Novartis, Bayer and Roche on Friday lost a bid to stop British doctors from recommending a cheaper drug option for people with an eye disease that causes blindness, the High Court in London ruled. (Source: Reuters: Health)
Source: Reuters: Health - September 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

European advisory panel recommends approval of Spark's gene therapy
The European Medicines Agency advisory panel voted Friday to recommend approval of Luxturna, a one-time gene therapy developed by Philadelphia-based Spark Therapeutics for an inherited eye disorder that leads to blindness if untreated. Luxturna received Food and Drug Administration approval in late 2017. The European Medicines Agency typically follows the removal of its advisory panels. If the treatment is approved in Europe, it would become the first gene therapy for a genetic disease approved… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2018 Category: Biotechnology Authors: John George Source Type: news

Why you should "never" sleep with contact lenses on
Health experts are urging the estimated 45 million Americans who wear contact lenses to change their habits. The CDC says sleeping in contacts can increase the risk of an eye infection by six to eight times. Dr. Christopher Starr, an ophthalmologist at Weill Cornell Medical Center, joins "CBS This Morning" to offer practical tips. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 21, 2018 Category: Consumer Health News Source Type: news

Diabetes, hypertension and obesity may increase fluid pressure inside the eye
Increased intraocular pressure is linked to diabetes, hypertension and obesity, according to a study published in theAmerican Journal of Ophthalmology.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 21, 2018 Category: Endocrinology Source Type: news

Outbreak of preventable eye infection in contact lens wearers
(University College London) A new outbreak of a rare but preventable eye infection that can cause blindness, has been identified in contact lens wearers in a new study led by UCL and Moorfields Eye Hospital researchers.The research team found a threefold increase in Acanthamoeba keratitis since 2011 in South-East England. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 21, 2018 Category: International Medicine & Public Health Source Type: news

Research Links Doctor Burnout to Patient Safety Incidents
Physician burnout linked to increased risk of patient safety incidents, reduced patient satisfaction (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 21, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Eating Fish During Pregnancy May Improve Baby ’ s Eyesight
BOSTON (CBS) – Pregnant women may be able to optimize their baby’s eyesight and brain function by regularly eating fatty fish during pregnancy. Researchers studied 56 mothers and their children in Finland and found that infants whose mothers ate fish three or more times a week during the last trimester did better on vision tests than those whose mothers ate little or no fish. Fish contain fatty acids, which are critical for nerve cells involved in eyesight and help brain cells communicate with one another. Pregnant women are currently advised to eat some fish but are also told to avoid fish that are high i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 20, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Watch Listen Dr. Mallika Marshall Eyesight Source Type: news

Taking a multivitamin every day could prevent vision loss from a common eye disease
(Natural News) Most of us take our vision for granted. We don’t really give our eyesight a second thought… until something is wrong with it. Unfortunately, there’s a good chance that you will run into vision problems as you age as a result of macular degeneration, and this can negatively affect your quality of life.... (Source: NaturalNews.com)
Source: NaturalNews.com - September 20, 2018 Category: Consumer Health News Source Type: news

Residents Should Take Advantage of Paid Time Off
Residents report making time for family, pursuing interests, and squeezing in important trips (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 20, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Heidelberg Engineering wins FDA nod for upgraded eye imaging technology
Image of an eye using OCTA technology, courtesy of Heidelberg Engineering. The FDA has approved Heidelberg Engineering’s optical coherence tomography angiography module (OCTA), the company said today. The module is available for new and existing Spectralis upgradeable diagnostic imaging devices used to manage diabetic retinopathy, age-related macular degeneration and other macular diseases. OCTA is a noninvasive imaging technique that provides three-dimensional visualization of perfused ocular vasculature. Structural OCT uses light waves to take cross-section pictures of the retina, allowing the ophtha...
Source: Mass Device - September 20, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Diagnostics Food & Drug Administration (FDA) Imaging Optical/Ophthalmic Vision heidelbergengineering Source Type: news

Fish-rich diets may boost babies' brain development
(Springer) Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy. This is the suggestion from a small-scale study led by Kirsi Laitinen of the University of Turku and Turku University Hospital in Finland, in the Springer Nature-branded journal Pediatric Research. The research supports previous findings that show how important a prospective mother's diet and lifestyle choices are for the development of her baby. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 20, 2018 Category: International Medicine & Public Health Source Type: news

FDA Clears New Form of Latanoprost (Xelpros) for Glaucoma FDA Clears New Form of Latanoprost (Xelpros) for Glaucoma
Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium chloride, a preservative commonly used in topical ocular preparations.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2018 Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news

Chemical in Cigarette Smoke May Damage Important Aspect of Vision Chemical in Cigarette Smoke May Damage Important Aspect of Vision
Exposure to a chemical in tobacco smoke could make it more difficult for people to see in low-contrast conditions, such as low light, fog or glare, a new study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2018 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Patient Health Information Often Shared Electronically
Most commonly observed types of PHI sent are referrals, laboratory results, medication lists (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 19, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Oculis Elects Anthony Rosenberg and David A. Weber - Veterans of the Global Pharmaceutical and Eye-care Industries - to its Board of Directors
LAUSANNE, Switzerland, September 19, 2018 -- (Healthcare Sales & Marketing Network) -- Oculis, a clinical-stage biotechnology company developing next-generation topical treatments for acute and chronic back- and front-of-the-eye diseases, announces the ap... Biopharmaceuticals, Ophthalmology, Personnel Oculis , Diabetic Macular Edema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2018 Category: Pharmaceuticals Source Type: news

Snooker in the live cell
(Umea University) The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. Yet, acute control of activity at distinct locations within a cell cannot be achieved. In the journal Angewandte Chemie, scientists from Ume å University (Sweden) and the Max Planck Institute of Molecular Physiology (Germany) present a new chemo-optogenetic method that enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 19, 2018 Category: Biology Source Type: news

Drug Prices Increase More Than Expected After Shortages
Expected price increase 20 percent for all drugs after shortage versus 9 percent in absence of shortage (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 18, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Compliance With Requirement to Report Results on EUCTR Is Poor
Half of trials on European Union Clinical Trials Register are non - compliant with requirements (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 18, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Second Sight Medical wins $2m NIH grant for Orion sight implant
Second Sight Medical (NSDQ:EYES) said today that it won a grant of nearly $2 million from the National Institutes of Health to back the early feasibility trial of its Orion device for the visually impaired. The Sylmar, Calif.-based company said the $1.6 million grant is part of a five-year, $6.3 million package that’s slated to fund the trial, which began in January. The NIH grant will cover the enrollment and treatment of five patients with Orion, a visual cortical implant that links to an eyeglass-worn camera, Second Sight said. The device is designed to bypass the optic nerve by sending the camera’s images t...
Source: Mass Device - September 18, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Optical/Ophthalmic Source Type: news

Incident Contrast Sensitivity Common in Middle-Aged Adults
TUESDAY, Sept. 18, 2018 -- The risk of incident contrast sensitivity (CS) impairment is increased with factors such as cadmium exposure and older age, according to a study published online Sept. 13 in JAMA Ophthalmology. Adam J. Paulsen, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 18, 2018 Category: Pharmaceuticals Source Type: news

Exercise found to protect your eyesight
(Natural News) Looking for ways to maintain your good eyesight? According to a study conducted by researchers from the University of California, Los Angeles, people who take part in moderate to intense physical activity have the capacity to curb their chances of developing glaucoma. The results of the research, presented at the 121st Annual Meeting... (Source: NaturalNews.com)
Source: NaturalNews.com - September 17, 2018 Category: Consumer Health News Source Type: news

Association Health Plans Can Help Small Businesses Offer Coverage
But AHPs may undermine ACA marketplace, as they are not required to comply with ACA regulations (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 17, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

(S)pot Check on Alternative Treatments for Glaucoma (S)pot Check on Alternative Treatments for Glaucoma
Does marijuana, gingko biloba, or bilberry effectively manage symptoms of glaucoma?Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 17, 2018 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

FDA Approves Xelpros (latanoprost ophthalmic emulsion) to Treat Open-angle Glaucoma or Ocular Hypertension
MUMBAI, India& PRINCETON, N.J.--(BUSINESS WIRE) September 14, 2018 --Sun Pharmaceutical Industries Ltd. and Sun Pharma Advanced Research Company Ltd. (SPARC) today announced U.S. Food and Drug Administration (USFDA) approval for the New Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 14, 2018 Category: Drugs & Pharmacology Source Type: news

Staar Surgical wins FDA nod for Visian Toric ICL
Staar Surgical (NSDQ:STAA) said yesterday that it won FDA approval for its Visian toric implantable collamer lens designed for correcting myopia with astigmatism. The Monrovia, Calif.-based company said that with the approval, its ICL product line is now cleared for the correction of refractive errors in patients with both myopia and astigmatism. Staar Surgical said that its ICLs in both spherical and toric designs have been associated with “significant improvements in quality of life,” and touted that patients who’ve received ICL surgery as “life changing,” according to a press rele...
Source: Mass Device - September 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance STAAR Surgical Co Source Type: news

Situation Framing, Language Can Influence Decision - Making
Docs should provide risks of both having treatment and not having treatment to minimize loss aversion (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 14, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

New approaches to the integration of navigation systems for autonomous unmanned vehicles - Konovalenko I, Kuznetsova E, Miller A, Miller B, Popov A, Shepelev D, Stepanyan K.
The article presents an overview of the theoretical and experimental work related to unmanned aerial vehicles (UAVs) motion parameters estimation based on the integration of video measurements obtained by the on-board optoelectronic camera and data from th... (Source: SafetyLit)
Source: SafetyLit - September 14, 2018 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults
However, in post - ACA era, lesbian, gay, bisexual adults still report trouble affording care (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 13, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

FDA to review Regeneron ’s Eylea for diabetic retinopathy
Regeneron Pharmaceuticals (NSDQ:REGN) said today that the FDA plans to review the supplemental biologics license application for Regeneron’s Eylea aflibercept injection for the treatment of diabetic retinopathy. The U.S. agency plans to make a decision about the blockbuster drug by May 13, 2019. Get the full story at our sister site, Drug Delivery Business News. The post FDA to review Regeneron’s Eylea for diabetic retinopathy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - September 13, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Featured Food & Drug Administration (FDA) Optical/Ophthalmic Pharmaceuticals Regulatory/Compliance Wall Street Beat Regeneron Source Type: news

FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
TARRYTOWN, N.Y., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ : REGN ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Appli... Biopharmaceuticals, Ophthalmology Regeneron Pharmaceuticals, EYLEA, aflibercept, diabetic retinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Six - Step Analysis Can Help Improve Practice Logistics
Method showed unfavorable traits related to match between supply, demand, access at outpatient clinic (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 12, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Anti-VEGF Effective in Persistent Diabetic Macular Edema Anti-VEGF Effective in Persistent Diabetic Macular Edema
A recent analysis associated three different anti-VEGF agents with meaningful vision gains through 2 years of follow-up.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2018 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Company led recall: Mydriasert 0.28mg/5.4mg Ophthalmic Insert
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company led recall for a specific batch of Mydriasert 0.28mg/5.4mg Ophthalmic Insert (Thea Pharmaceuticals) as it is labelle (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 12, 2018 Category: Drugs & Pharmacology Source Type: news

Diabetes type 2 symptoms: How to prevent eye problems associated with the condition
DIABETES type 2 is one of the leading causes of blindness in the UK, however sight loss associated with the blood sugar condition is preventable if the correct measures are taken. (Source: Daily Express - Health)
Source: Daily Express - Health - September 12, 2018 Category: Consumer Health News Source Type: news

Ophthalmic injuries related to maxillofacial trauma due to urban warfare - Mohammad NK, Al-Mahdi AH, Mohammed OM.
: Midfacial trauma commonly causes ocular injuries of varying degrees. Eye injuries account for approximately 10% of all battle injuries. Severity of injuries may range from a subconjunctival haemorrhage to optic nerve injury and globe laceration and ruptu... (Source: SafetyLit)
Source: SafetyLit - September 12, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

USPSTF Reaffirms Ocular Prophylaxis for All Newborns
(MedPage Today) -- Gonococcal ophthalmia neonatorum may cause perforation, blindness (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - September 11, 2018 Category: Infectious Diseases Source Type: news

Data Age in Clinical Trials Is About Three Years at Publication
Trials funded by government were associated with significantly longer time to publication (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 11, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Kaiser Permanente adding another Maryland medical center, this one in Prince George ’s
Kaiser Permanente of the Mid-Atlantic States is planning yet another medical center in the Baltimore/Washington, D.C., region. The Kaiser affiliate, now a few years into an aggressive regional expansion, announced plans for a new facility in Bowie to support its growing network. The building, which Kaiser will own, is scheduled to open in 2020. The 45,558-square-foot building at 5404 Hillmeade Road will offer primary car e, behavioral health, optometry, pharmacy, laboratory and imaging services,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 11, 2018 Category: Biotechnology Authors: Sara Gilgore Source Type: news

Kaiser Permanente adding another Maryland medical center, this one in Prince George ’s
Kaiser Permanente of the Mid-Atlantic States is planning yet another medical center in the Baltimore/Washington, D.C., region. The Kaiser affiliate, now a few years into an aggressive regional expansion, announced plans for a new facility in Bowie to support its growing network. The building, which Kaiser will own, is scheduled to open in 2020. The 45,558-square-foot building at 5404 Hillmeade Road will offer primary car e, behavioral health, optometry, pharmacy, laboratory and imaging services,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 11, 2018 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Regenerating light-sensing eye cells in mice
Researchers restored some vision in mice with congenital blindness by changing supportive cells in the retina called M üller glia into light-sensing cells. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - September 11, 2018 Category: Consumer Health News Source Type: news

Docs, Consumers Agree on Benefits of Virtual Care
But physician adoption of virtual care technologies is low; few plan to add video visit capability (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 10, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Corneal Infections Associated With Sleeping in Contact Lenses Corneal Infections Associated With Sleeping in Contact Lenses
These recent cases underscore the serious risks of sleeping with contact lenses--including corneal damage and possible permanent vision loss.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 10, 2018 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

Iridex wins FDA 510(k) for TruFocus LIO premiere ophthalmological laser
Iridex (NSDQ:IRIX) said yesterday it won FDA 510(k) clearance for its TruFocus LIO premiere ophthalmological laser accessory and that it launched the device in the US. The TruFocus LIO Premiere is a light combination and reflection viewing system designed to be used with the Iridex retina laser system, the Mountain View, Calif.-based company said. The newly cleared device is designed to be worn on the physician’s head and combines a laser treatment beam with the illumination beam of a binocular indirect ophthalmoscope into a mixed optical beam which can be used with a handheld examination lens to view and treat ...
Source: Mass Device - September 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Iridex Corp. Source Type: news

Swiss Advanced Vision launches Harmonis customizable IOL
Swiss Advanced Vision said yesterday it launched its Harmonis customizable intraocular lens system designed for cataract surgery. The newly launched system features advanced extended depth of focus optical technology, the Neuchatel, Switzerland-based company said, and a web-based configurator ophthalmologists can use prior to surgery to select optimal lens parameters. The web-based configurator offers selectable parameters for light ditribution ratios of near, intermediate and distance vision, reading distance and extended depth of focus, Swiss Advanced Vision said. “By expanding our product portfolio with the launch...
Source: Mass Device - September 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Swiss Advanced Vision Source Type: news